Most Clicked StoriesMore >


Document access policy to be updated by EMA

DIA Global SmartBrief | Feb 21, 2017

A proposal to revise the document access policy for transparency has been presented by the European Medicines Agency to increase publication of clinical data for medicinal products for pharmaceuticals and to extend its scope to include corporate documents. The agency is seeking public comments on the proposed revision until May 18. Regulatory Focus (02/17)


CMS nominee criticizes EpiPen pricing

DIA Global SmartBrief | Feb 21, 2017

Report: Drug-resistant bacteria pose threat across EU

DIA Global SmartBrief | Feb 23, 2017

Study: IBD patients can safely switch to biosimilar

DIA Global SmartBrief | Feb 21, 2017

Biosimilar cancer drugs being reviewed in Europe

DIA Global SmartBrief | Feb 21, 2017

AstraZeneca's COPD drug rejected by NICE

DIA Global SmartBrief | Feb 23, 2017

Upcoming DIA learning opportunities

DIA Global SmartBrief | Feb 21, 2017

India concerned about stent shortage after price cap

DIA Global SmartBrief | Feb 23, 2017

Generic lung cancer drug hits Chinese market

DIA Global SmartBrief | Feb 21, 2017

Upcoming DIA learning opportunities

DIA Global SmartBrief | Feb 23, 2017


Find DIA Global SmartBrief Issues by Date:



DIA News More >


Upcoming DIA learning opportunities

DIA Global SmartBrief | Feb 23, 2017

Medical Affairs and Scientific Communications Forum, March 13-15, Tucson, Ariz.

DIA Global SmartBrief | Feb 23, 2017

DIA events coming up next!

DIA Global SmartBrief | Feb 16, 2017

Advertising and Promotion Regulatory Affairs Conference
Feb. 23-24, Washington, D.C.

DIA Global SmartBrief | Feb 16, 2017

Upcoming DIA trainings and webinars

DIA Global SmartBrief | Feb 02, 2017




Sign up for DIA Global SmartBrief



Designed specifically for the global drug development professional, the DIA Global SmartBrief is a FREE, twice weekly e-mail newsletter. By providing the latest need-to-know industry news and information, the DIA Global SmartBrief saves you time and keeps you smart. Learn more